Cibus, Inc. (CBUS)
3.22
-0.11
(-3.30%)
USD |
NASDAQ |
Mar 05, 16:00
3.17
-0.05
(-1.55%)
After-Hours: 20:00
Cibus EPS Diluted (Quarterly) : -0.4448 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.30M |
| Revenue (Quarterly) | 0.615M |
| Total Expenses (Quarterly) | 24.16M |
| Enterprise Value | 449.86M |
| Gross Profit Margin (Quarterly) | -126.7% |
| Profit Margin (Quarterly) | -3.95K% |
| Earnings Yield | -99.97% |
| Normalized Earnings Yield | -86.38 |